Navigation Links
Access Pharmaceuticals Presents New Data at International Symposium Showing Company's Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
Date:6/26/2008

DALLAS, June 26 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced that the Company gave an oral presentation yesterday on its monoclonal antibody product, Angiolix(R), at the 7th International Congress on Recombinant Antibodies, held in Dublin, Ireland. Dr. Agamemnon Epenetos, Access' Chief Scientific Officer -- Europe, presented data showing that Angiolix has the potential to prevent the growth of cancer stem cells.

Dr. Epenetos commented, "There is a growing body of evidence that indicates that tumor progression, dissemination and metastases result from cancer stem cells rather than the other cells which form the bulk of a cancer. As a result, therapies which attack these tumor cells will delay the onset of progression, but rarely cure the disease. Cancer stem cells are a subgroup of cancer cells that can be resistant to standard treatments, so agents like Angiolix, which have the potential to thwart cancer stem cells, hold great promise for the future treatment and eradication of cancer."

Access' monoclonal antibody product, Angiolix, blocks angiogenesis by inhibiting a novel receptor called lactadherin. Lactadherin causes angiogenesis through a VEGF dependent mechanism. Several other drugs have been developed or are in development to block VEGF and VEGF induced angiogenesis, such as Avastin.

In the presentation, Dr. Epenetos showed that Angiolix has been shown not only to block new blood vessels in tumors, in a similar manner to other anti VEGF drugs like Avastin, but that it could additionally have a direct killing effect on tumor cells potentially including cancer stem cells that are involved in angiogenesis and metastasis.

Access Pharmaceuticals is currently conducting key preclinical studies at Imperial College London, UK to assess the efficacy of Angiolix in a wide range of tumor models. These studies aim to demonstrate the potential efficacy of Angiolix as a monotherapy and in com
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. CTI Enters Into Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data for Potential U.S. Supplemental Marketing Application
2. A Perfect Storm Threatens Patient Access to Specialty Medical Care
3. AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response
4. Access Licenses ProLindac(TM) to Jiangsu Aosaikang Pharmaceutical Co., LTD., a Leading Oncology Pharmaceutical Company for Manufacturing, Development and Commercialization in the Greater China Region
5. HistoRx Announces Expanded Access of AQUA(R) Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center
6. AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy
7. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
8. SurgiQuest Announces First Single Port Procedure for Ovary Removal Using AirSeal(TM) Access System
9. Scientists call for more access to biotech crop data
10. Perceptive Informatics Improves Clinical Site Monitoring Access and Flexibility With Portable USB Drive Capability
11. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... , DURHAM, N.C., Nov. 25 Resear...rst energy-efficient, single-treatment water purif...nanotubes to Andhra Pradesh, Minister of Rural Wat...s in Hyderabad, India today. Initial tests, perfor..., confirmed that the majority of the drinking wate...
(Date:11/25/2009)... , ,, BOCA RATON, Fla., Nov. 2...en a painful year. Not so for BodyLogicMD. The na...rt physicians specializing exclusively in medicall...e number of physicians in its network since ... in progress to add more physician-owned centers, ...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, Brazil Bioe..., http://www.reportlinker.com/p0165503/Brazil-Bio... ,, Brazil Bioethanol Market Analysis and Fore...vides detailed analysis and forecasts of the globa...
(Date:11/24/2009)..., HOUSTON, Nov. 24 IES...electrical and communications systems and services...rkets, announced today that its commercial busines... Torcon JV to install the electrical systems for t...lity at the U.S. Army Medical Research Institute o...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2
...TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) t...arter and year ended December 31, 2008. For the...1 million and a net loss of $22.8 million. Cash a...ber 31, 2008. , , On March 27, the Company filed...h included an audit opinion with a "going concern"...
... Biomedical, Inc., announced today that it will ma... progenitor cells commercially available to the re...otent human embryonic stem cells, ArunA,s hMC line...populations of mesenchymal cells in a feeder free ...com.com/cgi-bin/prnh/20080819/CLTU003LOGO ) , ...
... Catalyst Pharmaceutical Partners, Inc. (Nasdaq: ...s, in-licenses, develops and commercializes prescr...today reported financial results for the fourth qu...lyst made significant progress in 2008," said Patr...t Pharmaceutical Partners. "During the year, we i...
Other Biology Technology:TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 2TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 3TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 4TorreyPines Therapeutics Reports Fourth Quarter and Full Year 2008 Results 5ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Mesenchymal Cells 2Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 2Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 3Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 4Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 5Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results 6
(Date:11/26/2009)...deer have been caught in the hunters, sights for g...n decorative. They are lethal weapons that stags c... University of York, UK, has been intrigued by the...tury and has become fascinated by the mechanical p...oration with Tomas Landete-Castillejos at the Univ...
(Date:11/26/2009)...us Aureus ) and other drug-resistant bacteria coul...otype devices have been developed to offer safe, q..., Two prototype devices have been developed: one ...ands and feet) in hospitals and public spaces wher...o shoot bacteria-killing agents into infested chro...
(Date:11/25/2009)...th Research Laboratory in the University of Haifa,...tigious Johnson & Johnson Focused Funding grant fo...amage in Parkinson,s disease. The award, which is ...vation and excellence in science, was announced in... at an event at the Hyatt Regency Hotel in New Jer...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Scientists watch as peptides control crystal growth with switches throttles and brakes 10874 1Scientists watch as peptides control crystal growth with switches throttles and brakes 10874 2Scientists watch as peptides control crystal growth with switches throttles and brakes 10874 3Reportlinker Adds U S Market for PACS and EMR 6477 1Reportlinker Adds U S Market for PACS and EMR 6477 2Reportlinker Adds U S Market for PACS and EMR 6477 3Reportlinker Adds U S Market for PACS and EMR 6477 4Reportlinker Adds U S Market for PACS and EMR 6477 5Reportlinker Adds U S Market for PACS and EMR 6477 6Reportlinker Adds U S Market for PACS and EMR 6477 7Reportlinker Adds U S Market for PACS and EMR 6477 8Reportlinker Adds U S Market for PACS and EMR 6477 9Reportlinker Adds U S Market for PACS and EMR 6477 10Reportlinker Adds U S Market for PACS and EMR 6477 11Reportlinker Adds U S Market for PACS and EMR 6477 12Reportlinker Adds U S Market for PACS and EMR 6477 13Reportlinker Adds U S Market for PACS and EMR 6477 14Reportlinker Adds U S Market for PACS and EMR 6477 15Reportlinker Adds U S Market for PACS and EMR 6477 16Reportlinker Adds U S Market for PACS and EMR 6477 17Reportlinker Adds U S Market for PACS and EMR 6477 18Reportlinker Adds U S Market for PACS and EMR 6477 19Reportlinker Adds U S Market for PACS and EMR 6477 20Reportlinker Adds U S Market for PACS and EMR 6477 21Reportlinker Adds U S Market for PACS and EMR 6477 22Reportlinker Adds U S Market for PACS and EMR 6477 23Reportlinker Adds U S Market for PACS and EMR 6477 24Reportlinker Adds U S Market for PACS and EMR 6477 25Reportlinker Adds U S Market for PACS and EMR 6477 26Reportlinker Adds U S Market for PACS and EMR 6477 27Reportlinker Adds U S Market for PACS and EMR 6477 28Reportlinker Adds U S Market for PACS and EMR 6477 29Reportlinker Adds U S Market for PACS and EMR 6477 30Reportlinker Adds U S Market for PACS and EMR 6477 31Reportlinker Adds U S Market for PACS and EMR 6477 32Reportlinker Adds U S Market for PACS and EMR 6477 33Reportlinker Adds U S Market for PACS and EMR 6477 34Reportlinker Adds U S Market for PACS and EMR 6477 35Reportlinker Adds U S Market for PACS and EMR 6477 36Reportlinker Adds U S Market for PACS and EMR 6477 37Research Yields Clues to Severe Form of Sinusitis 61963 1Research Yields Clues to Severe Form of Sinusitis 61963 2
...an. 16, 2008) -- Two major federal grants have bee...l Medical College in New York City. , Dr. Kennet... million NIH grant from the National Institute on ...effects of a school-based drug-abuse prevention pr... attending New York City middle schools. The study...
...nuary 16, 2008) The latest medications can delay ...e to reverse its devastating effects. This limitat...ers patients maintaining a good quality of life fo...oped by the Georgia Institute of Technology and Em... inexpensive test that could be administered as pa...
... most significant questions facing marine ecologis...iations in the environment are having on the dispe...en oceans to coral reefs. Previously, tracking how...vation by divers on older larvae found near the re...kton. This method did not permit divers to follow ...
Other Biology News:2 federal public health grants awarded to Weill Cornell Medical College 2Portable device quickly detects early Alzheimer's 2Portable device quickly detects early Alzheimer's 3How baby fish find a home 2
...th circular clear acrylic chamber for complete vis...Oven features microprocessor operation for precise...e the unit., Carousel rotates at 11 rpm; manufact...able , Bottle Capacity - four 35 x 300mm bottles,...
...purification systems provide high speed purificati...ffer increased throughput and reproducible results...ingFisher, KingFisher mL and KingFisher 96, coveri...nsists of an instrument, specially designed plasti...
...Vac concentrator designed for the price-conscious ...ced, this unit still features a standard Teflon co... and heat. It is designed for use with aqueous sam...s for maximum sample flexibility., , Comes Standa...
SPD1010 Integrated SpeedVac System from Thermo Scientific
Biology Products: